Cargando…

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

BACKGROUND: This multi-centre phase II clinical trial is the first prospective evaluation of radioembolisation of patients with colorectal liver metastases (mCRC) who failed previous oxaliplatin- and irinotecan-based systemic chemotherapy regimens. METHODS: Eligible patients had adequate hepatic, ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cosimelli, M, Golfieri, R, Cagol, P P, Carpanese, L, Sciuto, R, Maini, C L, Mancini, R, Sperduti, I, Pizzi, G, Diodoro, M G, Perrone, M, Giampalma, E, Angelelli, B, Fiore, F, Lastoria, S, Bacchetti, S, Gasperini, D, Geatti, O, Izzo, F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920024/ https://www.ncbi.nlm.nih.gov/pubmed/20628388 http://dx.doi.org/10.1038/sj.bjc.6605770

Ejemplares similares

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres
por: Melucci, Elisa, et al.
Publicado: (2013)

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
por: Mahvash, Armeen, et al.
Publicado: (2016)

Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies
por: Sangro, Bruno, et al.
Publicado: (2018)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Zhen, Yanhua, et al.
Publicado: (2019)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
por: Cappelli, Alberta, et al.
Publicado: (2014)

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors
por: Kucuk, Ozlem N, et al.
Publicado: (2011)

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors
por: Kucuk, N Ozlem, et al.
Publicado: (2011)

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006)

Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
por: Mosconi, Cristina, et al.
Publicado: (2016)

Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
por: Paprottka, Karolin J., et al.
Publicado: (2021)

Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients
por: Bacchetti, Stefano, et al.
Publicado: (2009)

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
por: Depalo, Tommaso, et al.
Publicado: (2021)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma
por: Gabrielson, Andrew, et al.
Publicado: (2015)

Yttrium-90 microsphere induced gastrointestinal tract ulceration
por: South, Christopher D, et al.
Publicado: (2008)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
por: Westcott, Mark A., et al.
Publicado: (2016)

Highlighting Survival with Yttrium-90 Radioembolization Therapy in Unresectable Hepatocellular Carcinoma
por: Nabrinsky, Edward, et al.
Publicado: (2020)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study
por: Pietrangeli, Alberto, et al.
Publicado: (2009)

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis
por: Al-Adra, D.P., et al.
Publicado: (2015)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial
por: Chauhan, Nikhil, et al.
Publicado: (2018)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
por: Meyer, Carsten, et al.
Publicado: (2017)

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis
por: Dendy, Meaghan S., et al.
Publicado: (2017)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose
por: Chin, Re-I, et al.
Publicado: (2022)

Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review
por: Feretis, Michael, et al.
Publicado: (2020)

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization
por: Salem, Mohamed E., et al.
Publicado: (2013)

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
por: Benevolo, Maria, et al.
Publicado: (2011)

Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial
por: Chan, Stephen Lam, et al.
Publicado: (2022)

Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
por: Ghosh, Abheek, et al.
Publicado: (2022)

FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by (90)yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases
por: Pisani, Francesco, et al.
Publicado: (2011)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma
por: Van Thai, Nguyen, et al.
Publicado: (2021)

Successful treatment with yttrium-90 microspheres in a metastatic breast cancer patient and sclerosing cholangitis
por: Louvet, Aurélie, et al.
Publicado: (2021)

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 ((90)Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with (90)Y microspheres
por: Knešaurek, Karin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1abrqlqv1lmf15nnnkfdc6u8qt